Bharat Immunologicals (India) Management Performance Evaluation

BIBCL -- India Stock  

INR 11.26  0.37  3.18%

Analysis of Bharat Immunologicals manpower and management performance can provide insight into Bharat Immunologicals stock performance. Also an employee sentiment is becoming a valuable factor that investors can use to determine the amount of risk that may be associated with Bharat Immunologicals future performance. Check also Trending Equities.
Symbol  BIBCL
Name  Bharat Immunologicals Biologicals Corp Ltd
TypeStock
Country   India
Exchange  Bombay

Information on Bharat Immunologicals Biologicals Corp Ltd Leadership is currently not available.

If you believe this information is not accurate please let us know and we will check it out.

Currently Trending

XIC   
Purchased over 90 shares of
few hours ago
Traded for 23.535
C   
Purchased over 50 shares of
few hours ago
Traded for 55.77
V   
Purchased over 20 shares of
few hours ago
Traded for 137.54
F   
Purchased over 300 shares of
few hours ago
Traded for 8.5
S   
Purchased over 500 shares of
few hours ago
Traded for 6.07

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Bharat Immunologicals Management Effectiveness

The company has return on total asset (ROA) of (9.86) % which means that it has lost $9.86 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (10.18) % meaning that it generated substantial loss on money invested by shareholders.

Bharat Immunologicals Workforce Comparison

Bharat Immunologicals Biologicals Corp Ltd is number one stock in number of employees category among related companies. The total workforce of Biotechnology industry is currently estimated at about 674,649. Bharat Immunologicals adds roughly 5.0 in number of employees claiming only tiny portion of stocks in Biotechnology industry.

Bharat Immunologicals Profit Margins

The company has Profit Margin (PM) of (11.79) % which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (29.12) % which suggests for every $100 dollars of sales it generated a net operating loss of -0.29.

Bharat Immunologicals Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of thirty-nine. Bharat Immunologicals Price Series Summation is a cross summation of Bharat Immunologicals price series and its benchmark/peer. View also all equity analysis or get more info about price series summation math operators indicator.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Bharat Immunologicals Biologicals Corp Ltd to your portfolio
Check also Trending Equities. Please also try Equity Search module to search for activelly-traded equities including funds and etfs from over 30 global markets.
Search macroaxis.com